Right Person, Right Treatment, Right Time: Engaging Comorbid Populations With EHealth Interventions Across The Lifespan
Funder
National Health and Medical Research Council
Funding Amount
$622,655.00
Summary
I lead an innovative research program that is internationally recognised for its impact, research quality, and significant translational and commercial value. My work focuses on areas of critical need; increasing the evidence base and clinical translation of treatments for co-occurring (comorbid) mental and physical disorders. Over the next 5 years, I will focus on developing evidence to better match people with treatment, so that the right person receives the right treatment at the right time.
Glutamate - Adenosine Interactions And Drug-seeking
Funder
National Health and Medical Research Council
Funding Amount
$558,046.00
Summary
Substance abuse is a significant social and economic burdern upon Australian societies and on societies around the world. Treatment remains problematic due to the multi-layer nature of the disease, difficulties with treatment compliance and less than ideal treatment regimes. The present study aims to improve treatments for alcohol and drug abuse using a polypharmacy or multiple therapy approach, using pre-clinical models to determine the utility of this approach.
Molecular Cell Biology Of HNP22: Role In Alcohol Dependence
Funder
National Health and Medical Research Council
Funding Amount
$346,320.00
Summary
We used a differential screening procedure to detect changes in gene expression in the human alcoholic brain and described a novel gene, which we named hNP22, with increased expression in the superior frontal cortex of the alcoholic cases. This is the first report of a novel alcohol-responsive gene isolated from the human brain. We now propose to further explore the hNP22 gene, its product and its regulation in human brain tissue, and in a variety of experimental systems. We will determine how p ....We used a differential screening procedure to detect changes in gene expression in the human alcoholic brain and described a novel gene, which we named hNP22, with increased expression in the superior frontal cortex of the alcoholic cases. This is the first report of a novel alcohol-responsive gene isolated from the human brain. We now propose to further explore the hNP22 gene, its product and its regulation in human brain tissue, and in a variety of experimental systems. We will determine how protein expression correlates with the level of alcohol consumption. We will use animal and cell culture models to determine the response of the gene to various stimuli. We will express the recombinant protein to determine its function. It is likely that the gene product may be a component in an important signal pathway within neuronal cells and thus may represent a novel target for therapeutic intervention.Read moreRead less
Cortictropin Releasing Factor As A Therapeutic Target For Alcohol And Drug Abuse
Funder
National Health and Medical Research Council
Funding Amount
$504,097.00
Summary
A key problem with alcoholism, as with addiction generally, is the chronically relapsing nature of the disorder. This can be modelled in rodents and there is good general correspondence between animal studies of reinstatement and human experience of relapse. We have identified brain chemicals involved in this process. Consequently, by better understanding the biological mechanisms related to addiction and relapse, we will be in a position to counter this devastating condition.